Jiangxi Rimag Group (HKG:2522) incurred an attributable loss of 45.9 million yuan in 2024, compared with an attributable profit of 44.4 million yuan in the year-ago period, a March 28 filing with the Hong Kong bourse said.
Loss per share was 0.132 yuan, whereas the company had made earnings per share of 0.131 yuan in 2023.
The medical imaging solution services company's revenue fell by 18% to 760.6 million yuan in the year from 928.9 million yuan a year prior.